Production of sleeping-sickness treatment.
Pécoul
B
B
Gastellu
M
M
D003362:Cost-Benefit Analysis; D004339:Drug Compounding / Q000191:economics; D000518:Eflornithine / Q000009:adverse effects / Q000600:supply & distribution* / Q000627:therapeutic use; D006801:Humans; D008549:Melarsoprol / Q000009:adverse effects / Q000627:therapeutic use*; D013397:Sudan; D014344:Trypanocidal Agents / Q000009:adverse effects / Q000600:supply & distribution* / Q000627:therapeutic use; D014353:Trypanosomiasis, African / Q000188:drug therapy*; D014454:Uganda
D014344:Trypanocidal Agents; D008549:Melarsoprol; D000518:Eflornithine